Short description
Allysta is a biopharmaceutical company that develops therapeutic peptides for eye diseases.
Description
Allysta develops medicines for fibrosing diseases and ocular surface inflammations. They offer anti-inflammatory, anti-fibrotic, cell-regenerative, and beneficial metabolic properties that provide opportunities for development in multiple diseases.
Last funding
Cannot Access
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Bellevue, Washington, United States, North America
Founded on
January 1, 2014
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe
Sign in for full access